| Rank | Clinic Name | Patient Rating | Country | Lead Doctor | experience | Techniques | Best For | Why It’s Ranked | Accreditations |
|---|---|---|---|---|---|---|---|---|---|
| #1 | — / 5 | Shanghai, China | 26+ years | CAR T-cell therapy, CAR-NK therapy, epigenetic immunotherapy | High-risk or refractory lymphoma cases | 87.5% complete remission at 3 months for lymphoma. 1,500+ CAR-T infusions performed since 2014. Multidisciplinary tumor board manages each case. | — |